Skip to content

Pharmides

Active Private limited companyfounded 2022active for 4 yearsBoerenkrijgstraat 8, 3900 PeltKBO/BCE: BE 0781.475.649

Lifetime

4 annual accounts with figures on one time axis
peak of €45,701 in 2025
€45,701▲ 11.9%
peak of €30,503 in 2025
€30,503▲ 7.2%
peak of €115,992 in 2025
€115,992▲ 35.7%
€4,770▲ 69.0%
Board1 name since 2022
1 director
Documentsfilings and deeds
18-06-202643 days before the deadline
2025abbreviated format
Equity from €85,488 to €115,992Debts from €2,822 to €4,770Investments €24,968

Key points

from the 2025 annual accounts

Equity

€115,992 ▲ 35.7%

Pharmides has made a profit in every financial year since 2022.

Turnover

≈ €160,000 estimated

The abbreviated format states no turnover.

Investments

€24,968 4.7 times depreciation
2022202320242025

Green is investment, beige is depreciation.

Liquidity

16.87 was 23.98 in 2024

Short-term debts rose from €2,822 to €4,770.

Filings

4 annual accounts since 2022
AprilJune31 JulyOctober2022202320242025

The last four annual accounts were filed 34 to 43 days before the end of the period.

Position in the sector

96.0%

Higher solvency than 91% of companies in research and development. Sector median 46.1% · 345 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as Pharmides has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,329 companies, not a prediction for Pharmides. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 04-02-2022
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0781475649
Incorporation Founding capital of €4,000, 100 shares · Founded by (comparant) · appointed as director · published on 04-02-2022 · Gazette deed
First establishment Boerenkrijgstraat 8, Pelt
All 9 events

Comparable companies

same main activity, similar in size and age
Company
Pharmides Pelt €120,762 €45,701 96.0% -
FP-KOMPAS Beveren-Kruibeke-Zwijndrecht €144,235 €53,202 86.3% -
CVDH – Therapie & Consult Genk €110,115 €37,721 73.3% -
INDUSTRIAL FUTUR Namur €144,471 €62,205 67.3% -
HET LAMPJE Leuven €118,562 €20,431 25.0% -
VSB SOLUTIONS CONSULTING Ecaussinnes €190,001 €66,957 79.0% -
Op Kindermaat Asse €59,384 €36,231 6.6% -

These companies have the same main activity as Pharmides: scientific research and development (NACE 72200). They are comparable in size and age: total assets between €59,400 and €190,000, founded between 2022 and 2023.

Official details

Source: KBO
Status
Active since 02-02-2022Normal situation
Activity
Scientific research and developmentNACE 72200and 4 others
Establishment unit
2.327.275.5673900 Pelt, since 02-02-2022
Financial year end
31 December
Peppol
Reachable since 11-02-2025
Company details

Annual accounts 2025

€120,762▲ 36.7%
Filing
Filed on 18-06-2026, 43 days before the end of the filing period
Financials

Insights on Pharmides

Pharmides files the abbreviated format. That format states no turnover. The gross margin rose from €38,913 in 2022 to €45,701 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Pharmides

What is the company number of Pharmides?
The company number of Pharmides is 0781.475.649. The VAT number is the same number with BE in front: BE 0781.475.649.
Where is Pharmides based?
The registered office is at Boerenkrijgstraat 8, 3900 Pelt.Company details
What does Pharmides do?
According to the KBO register, the main activity is scientific research and development (NACE 72200).
What is the legal form of Pharmides?
Pharmides is a private limited company (BV).
When was Pharmides founded?
Pharmides was founded on 02-02-2022.
Is Pharmides still active?
Yes, Pharmides is an active enterprise in the KBO register.
What is the turnover of Pharmides?
The turnover in financial year 2025 is ≈ €160,000. This figure is estimated from the gross margin of €45,701 and 889 comparable companies of the same size. It probably lies between €87,000 and €330,000. It is a rough estimate.Financials
Is Pharmides profitable?
In financial year 2025, Pharmides made a profit of €30,503.
Where can I find the annual accounts of Pharmides?
Pharmides filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Pharmides due?
Pharmides must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.